Earnings Feed
Start Free
Home/Filings/4/0001209191-15-040806
4//SEC Filing

HYPERION THERAPEUTICS INC 4

Accession 0001209191-15-040806

CIK 0001386858operating
View on SEC.govCompany Profile

Filed

May 7, 8:00 PM ET

Accepted

May 8, 7:52 PM ET

Size

25.5 KB

Accession

0001209191-15-040806

Insider Transaction Report

Form 4
Period: 2015-05-07
HYPERION THERAPEUTICS INCHPTX
Santel Donald J
DirectorCEO & President
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07$46.00/sh−88,547$4,073,162→ 0 total
    Exercise: $7.31Exp: 2022-04-15→ Common Stock (88,547 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07−169→ 0 total
    Exercise: $327.95Exp: 2017-09-03→ Common Stock (169 underlying)
  • Disposition from Tender

    Common Stock

    2015-05-07$46.00/sh−10,164$467,544→ 0 total(indirect: By Trust)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07$46.00/sh−70,000$3,220,000→ 0 total
    Exercise: $25.97Exp: 2025-02-08→ Common Stock (70,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07$46.00/sh−303,133$13,944,118→ 0 total
    Exercise: $1.28Exp: 2019-11-02→ Common Stock (303,133 underlying)
  • Disposition from Tender

    Common Stock

    2015-05-07$46.00/sh−2,306$106,076→ 0 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07$46.00/sh−6,648$305,808→ 0 total
    Exercise: $4.08Exp: 2021-04-14→ Common Stock (6,648 underlying)
  • Disposition to Issuer

    Common Stock

    2015-05-07$46.00/sh−53,875$2,478,250→ 0 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07$46.00/sh−143,000$6,578,000→ 0 total
    Exercise: $24.46Exp: 2023-04-14→ Common Stock (143,000 underlying)
  • Disposition to Issuer

    Common Stock

    2015-05-07$46.00/sh−292,057$13,434,622→ 0 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07$46.00/sh−111,000$5,106,000→ 0 total
    Exercise: $26.74Exp: 2024-03-10→ Common Stock (111,000 underlying)
Footnotes (5)
  • [F1]Shares that were tendered pursuant to the offer from Horizon Pharma plc ("Horizon") to acquire shares of the issuer.
  • [F2]Restricted stock units covering shares of issuer common stock that will be cashed-out and cancelled in connection with the merger of the issuer and Horizon (the "Merger").
  • [F3]Shares that are being acquired by Horizon in the Merger.
  • [F4]Options to acquire shares of issuer common stock that will be cashed-out and cancelled in connection with the Merger.
  • [F5]Options to acquire shares of issuer common stock that will be cancelled for no consideration in connection with the Merger.

Documents

1 file

Issuer

HYPERION THERAPEUTICS INC

CIK 0001386858

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001386858

Filing Metadata

Form type
4
Filed
May 7, 8:00 PM ET
Accepted
May 8, 7:52 PM ET
Size
25.5 KB
View on SEC.gov